“Glucose-responsive – so-called smart – insulins are regarded as the holy grail of insulin as they would come as close to a ...

New data from the QWINT clinical trial may get Eli Lilly closer to bringing a once-weekly insulin injection to the US, ...

“This long-acting formulation could help address adherence ... Eli Lilly says phase 3 clinical trials indicate that its new weekly insulin injections were as effective as daily injections ...

Key drivers include technological advancements and evolving healthcare policies. The global market for short-acting insulin ...

and it now consists of pramlintide 0.6 mg/mL buffered at pH 4.0. The basic pharmacokinetics and pharmacodynamics of a 60-µg dose of the new pramlintide formulation when mixed with insulin remain ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes ...

Diabetes affects millions of Americans, with 1.4 million new cases diagnosed each year. This chronic condition is one of the ...

The medical examiner said the nurse requested a new insulin order with an increased dosage, but the approval was “pending review.” Bach was not seen by any medical staff for the next 19 hours ...

CHICAGO -- Hormone therapy for menopause symptoms reduced insulin resistance in healthy postmenopausal women, a systematic ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...